Immunotherapy: the lethal weapon against thoracic malignancies?

Symposium
Chairs: Rainer G. Wiewrodt (Münster, Germany), Maha Zohra Ladjemi (Brussels, Belgium)
Aims: To focus on the principles of immunotherapy and various clinical treatment strategies as immunotherapy will most likely change current practice in the treatment of thoracic malignancies; to highlight the most relevant clinical data regarding lung cancer and malignant pleural mesothelioma.

Rationale and targets of immunotherapy in thoracic malignancies Arnaud Scherpereel (Lille, France)
Current place and future of immunotherapy in lung cancer Thierry Berghmans (Brussels, Belgium)
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice? Steven Albelda (Philadelphia, United States of America)
How to select good candidates for immunotherapy against thoracic malignancies Sylvie Lantuejoul (Lyon, France)